BioNTech Results Presentation Deck
Infectious Diseases: A Long-term Growth Pillar
mRNA vaccines to combat major
global health burden
Malaria ¹:
Development of first mRNA-based
Malaria vaccine recently started
Implementation of sustainable
end-to-end vaccine supply
solutions in Africa planned
HIV and tuberculosis ²:
Preclinical development of
multiple product candidates
ongoing
Opportunity to impact infectious
diseases with high unmet need
Up to 10 mRNA vaccine candidates
in preclinical development³
9
1 Collaboration with KENUP Foundation; 2Collaboration with Bill & Melinda Gates Foundation; University of Pennsylvania collaboration
BNT161 influenza vaccine
candidate designed to improve
traditional vaccines
• FIH trial expected Q3 2021
Eligible for milestone payments
and royalties through Pfizer
agreement
BIONTECHView entire presentation